Home Stock

Stock Research: Ipca Laboratories

Independent stock analysis through peer comparison: Get the 360° View as an objective basis for stock decision-making and explore the detailed ranks.

Ipca Laboratories

BSE:524494 INE571A01020
77
  • Value
    39
  • Growth
    88
  • Safety
    Safety
    52
  • Combined
    76
  • Sentiment
    63
  • 360° View
    360° View
    77
Unlock
What factors are driving this 360° View?
Subscribe to View
Company Description

Ipca Laboratories Limited is an India-based integrated pharmaceutical company. It manufactures and markets over 350 formulations and approximately 80 active pharmaceutical ingredients (APIs), including brands like Zerodol and Lariago. Its products are sold in over 100 countries across the globe, with 18 manufacturing units in India. In the last fiscal year, the company had a market cap of $4314 million, profits of $657 million, revenue of $1046 million, and 18043 employees.

more
Strongest Rank Pro Holdings
Weakest Rank Capital Growth
Country India
Industry Pharmaceuticals
Size Medium
Website ipca.com
Index
Ipca Laboratories stock price by TradingView. Not sourced by Obermatt.
Similar Add to Watchlist Similar See Similar Stocks
The higher the 360° View, the better the stock performed against its peers, considering all metrics. The 360° View represents an average of the other 5 ranks and is then scaled to a rank from 1 to 100. The shaded values are illustrative only.
Last update: 18-Dec-2025.

Make Sense of the Ranks

The higher, the better. For every stock, we judge its performance against its peers and rank it on a scale of 1 to 100. These ranks are percentiles: a rank of 75 means the company outperforms 75% of its peers in that specific area. The higher the rank, the better the stock stacks up against its peers.

Value
Identifies how good a value the stock is.
Good Value Expensive
Combined
Consolidated view across Value, Growth, and Safety.
Good Tread Carefully
Growth
Shows a company's growth potential.
High Growth Tough Times
Sentiment
Shows what the market thinks of a stock.
Positive Sentiment Skepticism
Safety
Safety
Assesses how financially secure a company is.
Well-Financed High Leverage
360° View
360° View
Holistic stock analysis: all key non-/financial metrics
Good Watch Out

Detailed and Historical Ranks

Deep dive into 15 detailed ranks and 3 years of history. Unlock the analysis.

Unlock Ranks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
39 43 53 55
Growth
88 95 65 25
Safety
Safety
52 40 48 91
Sentiment
63 95 14 4
360° View
360° View
77 90 41 39
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Analyst Opinions
79 77 19 71
Opinions Change
41 71 50 13
Pro Holdings
n/a 81 43 16
Market Pulse
89 90 9 37
Sentiment
63 95 14 4
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Value
39 43 53 55
Growth
88 95 65 25
Safety Safety
52 40 48 91
Combined
76 76 73 75
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Price vs. Sales (P/S)
46 38 45 68
Price vs. Earnings (P/E)
60 52 65 53
Price vs. Book (P/B)
52 43 55 56
Dividend Yield
20 25 27 24
Value
39 43 53 55
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Revenue Growth
57 78 90 57
Profit Growth
65 86 80 8
Capital Growth
92 62 4 58
Stock Returns
47 79 57 31
Growth
88 95 65 25
Unlock Similar Stocks

Unlock all 15 detailed ranks and historical data for 6,500+ stocks.

Subscribe to Unlock
Metrics Current 2024 2023 2022
Leverage
46 44 42 76
Refinancing
59 52 70 66
Liquidity
47 28 37 84
Safety Safety
52 40 48 91

Similar Stocks

Discover high‑ranked alternatives to Ipca Laboratories and broaden your portfolio horizons.

Cipla

NSEI:CIPLA
Country: India
Industry: Pharmaceuticals
Size: Large
Full Stock Analysis

Fleury

BOVESPA:FLRY3
Country: Brazil
Industry: Health Care Services
Size: Medium
Full Stock Analysis

Maruti Suzuki

NSEI:MARUTI
Country: India
Industry: Automobile Manufacturers
Size: Large
Full Stock Analysis

Bosch

BSE:500530
Country: India
Industry: Auto Parts & Equipment
Size: Medium
Full Stock Analysis

Frequently Asked
Questions

This stock offers a high growth opportunity with safe financing and positive sentiment. It is typically expensive (low Value Rank), as investors pay a premium for high performance. It is for growth-focused investors comfortable paying a premium for a stock with strong future momentum.

Obermatt provides unbiased stock analysis as a completely independent third party. We have no conflicts of interest with individual stock titles. Our data-driven analysis is based on algorithms honed over twelve years, giving you analysis that is free from personal bias and conflicts of interest.

The 360° View Rank indicates a company's overall performance across all major financial and non-financial metrics tracked by Obermatt. A 360° View Rank of 75 means the company is more well-rounded than 75% of similar companies. A high score indicates that the company is strong across the board; it is attractively priced, growing sustainably, financially stable, and well-regarded by the market. Learn more.

Become an Obermatt subscriber and see all of the similar stocks here.

OTHER FEATURES

Use the Platform to its Fullest

The Obermatt Advantage

Ready to Elevate Your Investing?
Get Started Today

Choose the Obermatt subscription that best fits your needs.


30-day money back guarantee. Your subscription will renew until you cancel it, which you can do at any time.

What Our Customers Say

See how Obermatt improved their investing:

Review us See More Google Reviews